No phase 1. I wonder if it is because Maraviroc h
Post# of 145283
Quote:
The Phase 2 study is a single arm study with 30 patients designed to test the hypothesis that the combination of leronlimab, administered as a subcutaneous injection, and Regorafenib, administered orally, will increase progression-free survival in patients with CCR5-positive metastatic colorectal cancer.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)